BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Denschlag D, Thiel FC, Ackermann S, Harter P, Juhasz-Boess I, Mallmann P, Strauss HG, Ulrich U, Horn LC, Schmidt D, Vordermark D, Vogl T, Reichardt P, Gaß P, Gebhardt M, Beckmann MW. Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015). Geburtshilfe Frauenheilkd 2015;75:1028-42. [PMID: 26640293 DOI: 10.1055/s-0035-1558120] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu T, Zhang F, Yan H, Yu W, Chen M, Guan Y. A novel CDKN1A-JAZF1 gene fusion in low-grade endometrial stromal sarcoma arising from endometriosis in abdominal wall cesarean section scar: A case report and literature review. Taiwanese Journal of Obstetrics and Gynecology 2022;61:1082-1085. [DOI: 10.1016/j.tjog.2022.04.010] [Reference Citation Analysis]
2 Al-ibraheem A, Abdlkadir AS. The Outcome of Progressive Uterine Sarcoma with Potential Bone Involvement. World J Nucl Med 2022. [DOI: 10.1055/s-0042-1757285] [Reference Citation Analysis]
3 Petanovski Z, Kostova EP, Prodanova I, Ivkovska T, Dimitrov G. 2D/3D Ultrasound Findings of Uterine Carcinosarcoma: A Case Report and Literature Review. Donald School Journal of Ultrasound in Obstetrics and Gynecology 2022;16:148-152. [DOI: 10.5005/jp-journals-10009-1923] [Reference Citation Analysis]
4 Agaimy A, Clarke BA, Kolin DL, Lee CH, Lee JC, McCluggage WG, Pöschke P, Stoehr R, Swanson D, Turashvili G, Beckmann MW, Hartmann A, Antonescu CR, Dickson BC. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma. Am J Surg Pathol 2022. [PMID: 35575789 DOI: 10.1097/PAS.0000000000001915] [Reference Citation Analysis]
5 Neubrech F, Böhme P, Franke J, Kokott T. [Resection of an "inoperable" uterine sarcoma through the cooperation of plastic surgery and gynecology in a massively obese patient]. Handchir Mikrochir Plast Chir 2022. [PMID: 35158398 DOI: 10.1055/a-1722-3130] [Reference Citation Analysis]
6 Hiranuma K, Kusunoki S, Fujino K, Hirayama T, Nakahara M, Ujihira T, Yamaguchi M, Terao Y, Aiba M, Ogishima D, Matsumoto T, Itakura A. Management of Early Stage Uterine Adenosarcoma. Journal of Gynecologic Surgery 2022;38:66-71. [DOI: 10.1089/gyn.2021.0031] [Reference Citation Analysis]
7 Adewole AA, Onile TG, Ugiagbe AO, Fadahunsi OO, Awelimobor DI, Akinro O. Cervical leiomyosarcoma in a teenage girl: A rare form of uterine leiomyosarcoma. Journal of Taibah University Medical Sciences 2021. [DOI: 10.1016/j.jtumed.2021.10.007] [Reference Citation Analysis]
8 Tajiri T, Mima K, Kanemitsu K, Takematsu T, Kosumi K, Inoue M, Mizumoto T, Kubota T, Muto R, Murayama T, Miyanari N, Baba H. Endometrial stromal sarcoma of the sigmoid colon: a case report and literature review. Int Cancer Conf J 2021;10:294-9. [PMID: 34567941 DOI: 10.1007/s13691-021-00493-z] [Reference Citation Analysis]
9 Sun H, Ma L, Chen J. Hyaluronan-mediated motility receptor expression functions as a prognostic biomarker in uterine carcinosarcoma based on bioinformatics analysis. J Int Med Res 2021;49:3000605211021043. [PMID: 34111996 DOI: 10.1177/03000605211021043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Kyriazoglou A, Liontos M, Ntanasis-Stathopoulos I, Gavriatopoulou M. The systemic treatment of uterine leiomyosarcomas: A systematic review. No news is good news? Medicine (Baltimore) 2021;100:e25309. [PMID: 33787622 DOI: 10.1097/MD.0000000000025309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Agrawal A, Huang K, Lai S. Laparoscopic Staging of Uterine Carcinosarcoma Following Radiotherapy for Cervical Cancer. Journal of Gynecologic Surgery 2021;37:86-8. [DOI: 10.1089/gyn.2020.0094] [Reference Citation Analysis]
12 Sasaki K, Takemoto S, Saiki N, Ando M, Takamatsu A, Sato M, Asada H, Fukunaga M. Two Cases of Juvenile Endometrial Cancer who could choose fertility-sparing treatment by Transcervical Resection. JAPANESE JOURNAL OF JSGOE 2021;37:123-130. [DOI: 10.5180/jsgoe.37.1_123] [Reference Citation Analysis]
13 Dannecker C, Himsl I, von Koch FE, Schäfer SD, Schweppe K. Erkrankungen des Uterus. Facharztwissen Gynäkologie 2021. [DOI: 10.1016/b978-3-437-23917-5.00013-6] [Reference Citation Analysis]
14 Capozzi VA, Monfardini L, Ceni V, Cianciolo A, Butera D, Gaiano M, Berretta R. Endometrial stromal sarcoma: A review of rare mesenchymal uterine neoplasm. J Obstet Gynaecol Res 2020;46:2221-36. [PMID: 32830415 DOI: 10.1111/jog.14436] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
15 Wu J, Zhang H, Li L, Hu M, Chen L, Xu B, Song Q. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis. Cancer Commun (Lond) 2020;40:301-12. [PMID: 32558385 DOI: 10.1002/cac2.12067] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
16 Hapsari K, Bhugwandass C, van Rijn GWJ, van der Wurff AAM, van ‘t Veer M, Boll D, Vos MC, Pijlman B, Kok A, Piek JMJ. Treatment and Outcome of Patients with Uterine Carcinosarcoma in a Comprehensive Cancer Network. Indian J Gynecol Oncolog 2020;18:17. [DOI: 10.1007/s40944-019-0362-6] [Reference Citation Analysis]
17 Zhang Y, Li N, Wang W, Yao H, An J, Li N, Sun Y, Wu L. Long-term impact of lymphadenectomies in patients with low-grade, early-stage uterine endometrial stroma sarcoma. J Obstet Gynaecol Res 2020;46:654-62. [PMID: 32022392 DOI: 10.1111/jog.14198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
18 L'Heveder A, Jones BP, Saso S, Barcroft J, Richardson R, Kaur B, Ghaem-Maghami S, Yazbek J, Smith JR. Conservative management of uterine adenosarcoma: lessons learned from 20 years of follow-up. Arch Gynecol Obstet 2019;300:1383-9. [PMID: 31584132 DOI: 10.1007/s00404-019-05306-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Horn LC, Emons G, Aretz S, Bock N, Follmann M, Lax S, Nothacker M, Steiner E, Mayr D; Deutsche Krebsgesellschaft (DKG)., Kommission zur Erstellung der S3-Leitlinie „Diagnostik, Therapie und Nachsorge der Patientinnen mit Endometriumkarzinom“. [S3 guidelines on the diagnosis and treatment of carcinoma of the endometrium : Requirements for pathology]. Pathologe 2019;40:21-35. [PMID: 30756154 DOI: 10.1007/s00292-019-0574-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
20 Meseci E, Naki MM. Prognostic factors, survival outcomes, and surgical practices when dealing with uterine sarcomas: 8 years’ clinical experience. J Turk Ger Gynecol Assoc 2019;20:154-64. [PMID: 31298514 DOI: 10.4274/jtgga.galenos.2019.2019.0061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Xu Y, Liang ZX, Guo JT, Su X, Lu YL, Guan XZ. Cystic and solitary nodular pulmonary metastases in a patient with low-grade endometrial stromal sarcoma: A case report and literature review. Oncol Lett 2019;18:1133-44. [PMID: 31423173 DOI: 10.3892/ol.2019.10409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Zhang Y, Chen C, Ren M, Cong X, Li Z, Yang L. Treatment of uterine high-grade endometrial stromal sarcoma with apatinib combined with chemotherapy: A case report. Medicine (Baltimore) 2019;98:e15050. [PMID: 30921232 DOI: 10.1097/MD.0000000000015050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Ulrich UA, Denschlag D. Uterine Adenosarcoma. Oncol Res Treat 2018;41:693-6. [DOI: 10.1159/000494067] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
24 Denschlag D, Ulrich UA. Uterine Carcinosarcomas - Diagnosis and Management. Oncol Res Treat 2018;41:675-9. [PMID: 30317231 DOI: 10.1159/000494335] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
25 Thiel FC, Halmen S. Low-Grade Endometrial Stromal Sarcoma - a Review. Oncol Res Treat. 2018;41:687-692. [PMID: 30317238 DOI: 10.1159/000494225] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
26 Díaz-montes TP, El-sharkawy F, Lynam S, Harper A, Sittig M, Macdonald R, Gushchin V, Sardi A. Efficacy of Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Treatment of Recurrent Uterine Sarcoma: . International Journal of Gynecological Cancer 2018;28:1130-7. [DOI: 10.1097/igc.0000000000001289] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
27 Sardi A, Muñoz-Zuluaga CA, Sittig M, Diaz-Montes T. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma. Clin Case Rep 2018;6:1142-52. [PMID: 29881584 DOI: 10.1002/ccr3.1491] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
28 Bužinskienė D, Mikėnas S, Drąsutienė G, Mongirdas M. Uterine sarcoma: a clinical case and a literature review. Acta Med Litu 2018;25:206-18. [PMID: 31308826 DOI: 10.6001/actamedica.v25i4.3931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
29 Sardi A, Sipok A, Baratti D, Deraco M, Sugarbaker P, Salti G, Yonemura Y, Sammartino P, Glehen O, Bakrin N, Díaz-Montes TP, Gushchin V. Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2017;43:2170-7. [PMID: 28967566 DOI: 10.1016/j.ejso.2017.08.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
30 Horn LC, Mayr D, Brambs CE, Einenkel J, Sändig I, Schierle K. [Grading of gynecological tumors : Current aspects]. Pathologe 2016;37:337-51. [PMID: 27379622 DOI: 10.1007/s00292-016-0183-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
31 Horng HC, Wen KC, Wang PH, Chen YJ, Yen MS, Ng HT; Taiwan Association of Gynecology Systematic Review Group. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review. Taiwan J Obstet Gynecol. 2016;55:472-479. [PMID: 27590366 DOI: 10.1016/j.tjog.2016.04.034] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
32 Li J, Xing X, Li D, Zhang B, Mutch DG, Hagemann IS, Wang T. Whole-Genome DNA Methylation Profiling Identifies Epigenetic Signatures of Uterine Carcinosarcoma. Neoplasia 2017;19:100-11. [PMID: 28088687 DOI: 10.1016/j.neo.2016.12.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
33 Dannecker C, Himsl I, Koch FEV, Schweppe K. Erkrankungen des Uterus. Facharztwissen Gynäkologie 2017. [DOI: 10.1016/b978-3-437-23916-8.00013-5] [Reference Citation Analysis]
34 Muñoz-zuluaga CA, Sipok A, Sardi A. Management of Peritoneal Metastasis from Uterine Sarcoma. Unusual Cases in Peritoneal Surface Malignancies 2017. [DOI: 10.1007/978-3-319-51523-6_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
35 Wen K, Horng H, Wang P, Chen Y, Yen M, Ng H, Chang Y, Chang Y, Chao H, Chao K, Chuang C, Ho C, Huang C, Hung Z, Jiang L, Lau H, Li H, Lin C, Liu C, Sun P, Twu N, Wu H, Yu H, Ju F, Tsai C, Chang W, Hsu Y, Lee N, Chen C, Chang T, Chang W, Chen C, Chen R, Chow S, Lien Y, Sheu B, Torng P, Yen M, Lee W, Wang K, Chang C, Chen C, Chen J, Chen T, Huang J, Huang M, Wang Y, Chang C, Liu J, Su H, Wang Y, Yu M, Huang L, Seow K, Lai T, Lee F, Chen C, Huang B, Hsiao S, Sun H, Wu W, Teng S, Chen K, Hung J, Lai H, Yuan C, Hsieh C, Wang C, Chang S, Hung M, Hsu S, Ke Y, Lu C, Sun L, Chang W, Hung Y, Lin W, Wang P, Chen T, Li Y, Wu M, Huang K, Fu H, Chen S, Chiang A, Li J, Lin L, Tsai H, Tsui K. Uterine sarcoma Part I—Uterine leiomyosarcoma: The Topic Advisory Group systematic review. Taiwanese Journal of Obstetrics and Gynecology 2016;55:463-71. [DOI: 10.1016/j.tjog.2016.04.033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
36 Wallwiener C, Hartkopf A, Kommoss S, Joachim C, Wallwiener M, Taran FA, Brucker S. Clinical Characteristics, Surgical Management and Adjuvant Therapy of Patients with Uterine Carcinosarcoma: A Retrospective Case Series. Geburtshilfe Frauenheilkd 2016;76:188-93. [PMID: 26941453 DOI: 10.1055/s-0042-100205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
37 Denschlag D, Thiel FC, Beckmann MW, Mallmann P. Heterogene Malignome erfordern differenzierte Therapiestrategien. gynäkologie + geburtshilfe 2016;21:25-32. [DOI: 10.1007/s15013-016-0846-8] [Reference Citation Analysis]